TD Cowen Starts Recursion Pharmaceuticals (RXRX) at Market Perform, 'Distinguished Platform But Biz Model Gives Pause'
Tweet Send to a Friend
(Updated - January 26, 2024 5:34 AM EST)
TD Cowen analyst Steven Mah initiates coverage on Recursion Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
TD Cowen analyst Steven Mah initiates coverage on Recursion Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
